Study on the Immediate Analgesic Effect of Yanglingquan Acupoint Treatment for Biliary Colic

NCT07194655 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 248

Last updated 2025-09-26

No results posted yet for this study

Summary

Guided by traditional meridian and acupoint theory, conducting standardized, large-sample, multicenter randomized controlled trials (RCTs) to evaluate the clinical efficacy of pattern differentiation and meridian-based acupoint selection for biliary colic across multiple levels can provide high-quality research evidence for developing evidence-based guidelines or optimal treatment protocols. This holds significant importance for enhancing the clinical efficacy of acupuncture in treating biliary colic and promoting its widespread clinical application. Therefore, this study will conduct a multicenter, large-sample randomized controlled trial comparing the clinical effects of acupuncture at Yanglingquan (GB34) versus drug therapy for acute cholecystitis biliary colic. It aims to investigate the clinical efficacy and safety of acupuncture treatment for acute cholecystitis biliary colic.

Conditions

  • Biliary Colic

Interventions

OTHER

Acupuncture at the Yanglingquan point

Acupuncture at the Yanglingquan point

OTHER

Acupuncture at the Xiabai Point

Acupuncture at the Xiabai Point

OTHER

Acupuncture at non-meridian points

Acupuncture at non-meridian points

Sponsors & Collaborators

  • Tianjin Medical University General Hospital

    collaborator OTHER
  • Tianjin Hospital of Integrated Traditional Chinese and Western Medicine

    collaborator UNKNOWN
  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2026-10-31
Completion
2026-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07194655 on ClinicalTrials.gov